Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Updates from ACC 2023: Examining Transcatheter Repair Study Data
Updates from ACC 2023: Examining Transcatheter Repair Study Data
ACC Action Center
Updates from ACC 2023: Examining Transcatheter Repair Study Data
- Paul Sorajja, MD
Closing Gaps in Care for Patients with T2D & CV Disease
Closing Gaps in Care for Patients with T2D & CV Disease
Diabetes Discourse
Closing Gaps in Care for Patients with T2D & CV Disease
- John Buse, MD, PhD
- Jennifer B. Green, MD
Cardio-Oncology: Key Clinical Data from ACC.23
Cardio-Oncology: Key Clinical Data from ACC.23
ACC Action Center
Cardio-Oncology: Key Clinical Data from ACC.23
- Ana Barac, MD, PhD
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
ACC Action Center
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
- Javed Butler
- Ana Barac, MD, PhD